View More View Less
  • 1 Kitasato University School of Medicine Department of Pharmacology Sagamihara, Kanagawa 228-8555 Japan
  • 2 Higashi 1-14-3, Shibuya-ku Tokyo 150-0011 Japan
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

It has been reported that only one-third of normotensive subjects and half of hypertensive patients are salt-sensitive. Many causes of salt-sensitivity have been proposed. Our suggestion is that a reduced urinary kallikrein level may be one cause, since mutant kininogen-deficient rats, which cannot generate kinin in the urine, are salt-sensitive. Renal kallikrein is secreted by the connecting tubule cells of the kidney, which are located just distal to the macula densa or the tubuloglomerular feedback system. Excess amounts of sodium taken overflow into the distal tubules and are reabsorbed in the collecting ducts. Kinins generated inhibit sodium reabsorption in the collecting ducts. Both blacks and whites with essential hypertension excrete less urinary kallikrein than do their normotensive counterparts, but the mean value in “normotensive blacks” were not different from that in “hypertensive whites”. African-Americans consume less potassium than whites. Potassium and ATP-sensitive potassium channel blockers are releasers of renal kallikrein. In a small-scale study, sodium loading caused more increase in the systolic blood pressure in urinary low-kallikrein group than in urinary high-kallikrein group. Largescale clinical studies, under strict control of potassium intake, are needed to elucidate the relationship between salt-sensitivity and urinary kallikrein levels.

  • Elliott P, Dyer A, Stamler R: The INTERSALT study: results for 24 hour sodium and potassium, by age and sex. INTERSALT Co-operative Research Group. J. Hum. Hypertens. 3, 323–330 (1989)

    Stamler R. , 'The INTERSALT study: results for 24 hour sodium and potassium, by age and sex. INTERSALT Co-operative Research Group ' (1989 ) 3 J. Hum. Hypertens. : 323 -330.

    • Search Google Scholar
  • Elliott P, Mamot M, Dyer A, Joossens J, Kesteloot H, Stamler R, Stamler J, Rose G: The INTERSALT study: main results, conclusions and some implications. Clin. Exp. Hypertens. A. 11, 1025–1034 (1989)

    Rose G. , 'The INTERSALT study: main results, conclusions and some implications ' (1989 ) 11 Clin. Exp. Hypertens. A. : 1025 -1034.

    • Search Google Scholar
  • Jones D: Dietary sodium and blood pressure. Hypertension 44, e12 (2004)

    Jones D. , 'Dietary sodium and blood pressure ' (2004 ) 44 Hypertension : e12 -.

  • Davis M, Jones D: The role of lifestyle management in the overall treatment plan for prevention and management of hypertension. Semin. Nephrol. 22, 35–43 (2002)

    Jones D. , 'The role of lifestyle management in the overall treatment plan for prevention and management of hypertension ' (2002 ) 22 Semin. Nephrol. : 35 -43.

    • Search Google Scholar
  • Jones D: What is the role of obesity in hypertension and target organ injury in African American? Am. J. Med. Sci., 317, 147–151 (1999)

    Jones D. , 'What is the role of obesity in hypertension and target organ injury in African American? ' (1999 ) 317 Am. J. Med. Sci. : 147 -151.

    • Search Google Scholar
  • Weinberger M: Salt sensitivity of blood pressure in humans. Hypertension 27, 4411–4490 (1996)

    Weinberger M. , 'Salt sensitivity of blood pressure in humans ' (1996 ) 27 Hypertension : 4411 -4490.

    • Search Google Scholar
  • Weinberger M: Salt sensitivity; does it play an important role in the pathogenesis and treatment of hypertension? Curr. Opin. Nephrol. Hypertens. 5, 205–208 (1996)

    Weinberger M. , 'Salt sensitivity; does it play an important role in the pathogenesis and treatment of hypertension? ' (1996 ) 5 Curr. Opin. Nephrol. Hypertens. : 205 -208.

    • Search Google Scholar
  • Weinberger M: Salt and blood pressure. Curr. Opin. Nephrol. Hypertens. 15, 254–257 (2000)

    Weinberger M. , 'Salt and blood pressure ' (2000 ) 15 Curr. Opin. Nephrol. Hypertens. : 254 -257.

    • Search Google Scholar
  • Weinberger M: More on the sodium saga. Hypertension 44, 609–611 (2004)

    Weinberger M. , 'More on the sodium saga ' (2004 ) 44 Hypertension : 609 -611.

  • Weinberger M: Sodium and blood pressure. Curr. Opin. Cardiol. 19, 353–356 (2004)

    Weinberger M. , 'Sodium and blood pressure ' (2004 ) 19 Curr. Opin. Cardiol. : 353 -356.

  • Katori M, Majima M: The renal kallikrein-kinin system: Its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension. Crit. Rev. Clin. Lab. Sci. 40, 43–115 (2003)

    Majima M. , 'The renal kallikrein-kinin system: Its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension ' (2003 ) 40 Crit. Rev. Clin. Lab. Sci. : 43 -115.

    • Search Google Scholar
  • Obarzanek E, Proschan M, Vollmer W, Moore T, Sacks F, Appel L, Svetkey L, Most-Winchauser M, Cutler J: Individual blood pressure responses to changes in salt take: results from the DASH-Sodium trial. Hypertension 42, 459–467 (2003)

    Cutler J. , 'Individual blood pressure responses to changes in salt take: results from the DASH-Sodium trial ' (2003 ) 42 Hypertension : 459 -467.

    • Search Google Scholar
  • Kawasaki T, Delea C, Bartter F, Smith H: The effect of high-sodium and low-sodium intake on blood pressure and other related variables in human subjects with idopathic hypertension. Am. J. Med. 64, 193–198 (1978)

    Smith H. , 'The effect of high-sodium and low-sodium intake on blood pressure and other related variables in human subjects with idopathic hypertension ' (1978 ) 64 Am. J. Med. : 193 -198.

    • Search Google Scholar
  • Weinberger M, Miller J, Luft F, Grim C, Fineberg N: Definitions and characteristics of sodium sensitivity and resistance of blood pressure. Hypertension 8(6 Pt 2), Suppl II, 127–134 (1986)

    Fineberg N. , 'Definitions and characteristics of sodium sensitivity and resistance of blood pressure ' (1986 ) 8 Hypertension : 127 -134.

    • Search Google Scholar
  • Weinberger M, Fineberg N: Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension. 18, 67–71 (1991)

    Fineberg N. , 'Sodium and volume sensitivity of blood pressure. Age and pressure change over time ' (1991 ) 18 Hypertension : 67 -71.

    • Search Google Scholar
  • Katori M, Majima M: A missing link between a high salt intake and blood pressure increase. J. Pharmacol. Sci., 100, 370–390 (2006)

    Majima M. , 'A missing link between a high salt intake and blood pressure increase ' (2006 ) 100 J. Pharmacol. Sci. : 370 -390.

    • Search Google Scholar
  • Crowley S, Gurley S, Oliverio M, Pazmino A, Griffiths R, Flannery P, Spurney RF, Kim H-S, Oliver S, Le TH, Coffman TM: Distinct role for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J. Clin. Invest. 115, 1092–1099 (2005)

    Coffman T.M. , 'Distinct role for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system ' (2005 ) 115 J. Clin. Invest. : 1092 -1099.

    • Search Google Scholar
  • Majima M, Katori M: Approaches to the development of novel antihypertensive drugs: Crucial role of the renal kallikrein-kinin system. Trends Pharmacol. Sci. 16, 239–246 (1995)

    Katori M. , 'Approaches to the development of novel antihypertensive drugs: Crucial role of the renal kallikrein-kinin system ' (1995 ) 16 Trends Pharmacol. Sci. : 239 -246.

    • Search Google Scholar
  • Katori M, Majima M: Pivotal role of renal kallikrein-kinin system in the development of hypertension and approaches to new drugs based on this relationship. Jpn. J. Pharmacol. 70, 95–128 (1996)

    Majima M. , 'Pivotal role of renal kallikrein-kinin system in the development of hypertension and approaches to new drugs based on this relationship ' (1996 ) 70 Jpn. J. Pharmacol. : 95 -128.

    • Search Google Scholar
  • Katori M, Majima M: Preventive role of renal kallikrein-kinin system in the early phase of hypertension and development of new antihypertensive drugs. Adv. Pharmacol. 44, 147–224 (1998)

    Majima M. , 'Preventive role of renal kallikrein-kinin system in the early phase of hypertension and development of new antihypertensive drugs ' (1998 ) 44 Adv. Pharmacol. : 147 -224.

    • Search Google Scholar
  • Maddox D, Brenner B (1996): Glomerular Ultrafiltration. In: The Kidney. Vol. 1, Eds Brenner B, W.B. Saunders Company, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, pp. 286–333

    Brenner B. , '', in The Kidney. Vol. 1 , (1996 ) -.

  • Orstabik T, Nustad K, Brandtzadeeg P, Pierce J: Cellular origin of urinary kallikrein. J. Histochem. Cytochem. 24, 1037–1039 (1976)

    Pierce J. , 'Cellular origin of urinary kallikrein ' (1976 ) 24 J. Histochem. Cytochem. : 1037 -1039.

    • Search Google Scholar
  • Orstavvik T, Inagami T: Localization of kallikrein in the rat kidney and its anatomical relationship to renin. J. Histochem. Cytochem., 30, 385–390 (1982)

    Inagami T. , 'Localization of kallikrein in the rat kidney and its anatomical relationship to renin ' (1982 ) 30 J. Histochem. Cytochem. : 385 -390.

    • Search Google Scholar
  • Vio CP, Figueroa CD: Subcellular localization of renal kallikrein by ultrastructural immunochemistry. Kidney Int. 28, 36–42 (1985)

    Figueroa C.D. , 'Subcellular localization of renal kallikrein by ultrastructural immunochemistry ' (1985 ) 28 Kidney Int : 36 -42.

    • Search Google Scholar
  • Figueroa CD, Caorsi I, Vio CP: Visualization of renal kallikrein in luminal and basolateral membranes. J. Histochem. Cytochem. 32, 1238–1240 (1984)

    Vio C.P. , 'Visualization of renal kallikrein in luminal and basolateral membranes ' (1984 ) 32 J. Histochem. Cytochem. : 1238 -1240.

    • Search Google Scholar
  • Figueroa C, MacIver A, Mackenzie J, Bhoola K: Localization of immunoreactive kininogen and tissue kallikrein in the human nephron. Histochemistry 89, 437–442 (1988)

    Bhoola K. , 'Localization of immunoreactive kininogen and tissue kallikrein in the human nephron ' (1988 ) 89 Histochemistry : 437 -442.

    • Search Google Scholar
  • Fujita T, Kumagai Y, Ikeda Y, Inamura N, Iwata T, Ogino M, Majima M: Involvement of the renal kallikrein-kinin system in furosemide-induced natriuresis in rats. Jpn. J. Pharmacol. 84, 133–139 (2000)

    Majima M. , 'Involvement of the renal kallikrein-kinin system in furosemide-induced natriuresis in rats ' (2000 ) 84 Jpn. J. Pharmacol. : 133 -139.

    • Search Google Scholar
  • Seino M, Abe M, Irokawa N, Ito T, Yasujima M, Sakurai Y, Chiba S, Saito K, Ritz K, Kusaka T, Miyazaki S, Yoshinaga K: Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension. Tohoku J. Exp. Med. 124, 197–203 (1978)

    Yoshinaga K. , 'Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension ' (1978 ) 124 Tohoku J. Exp. Med. : 197 -203.

    • Search Google Scholar
  • Zschiedrich H, Fleckenstein P, Geiger R, Fink E, Sinterhauf K, Philipp T, Philipp T, Distler A: Urinary kallikrein in normotensive subjects and in patients with essential hypertension. Clin. Exp. Hypertens. 2, 693–708 (1980)

    Distler A. , 'Urinary kallikrein in normotensive subjects and in patients with essential hypertension ' (1980 ) 2 Clin. Exp. Hypertens. : 693 -708.

    • Search Google Scholar
  • Majima M, Katori M, Ogino M, Saito M, Sugimoto K, Adachi K, Sunahara N, Katoh K, Tatemachi N, Takei Y: Failure of endogenous blood kinin levels elevated by captopril to induce hypotension in normotensive and hypertensive rats. An assay for kinin by a new ELISA. Biochem. Res. 17, 698–708 (1993)

    Takei Y. , 'Failure of endogenous blood kinin levels elevated by captopril to induce hypotension in normotensive and hypertensive rats. An assay for kinin by a new ELISA ' (1993 ) 17 Biochem. Res. : 698 -708.

    • Search Google Scholar
  • Majima M, Katori M, Ogino M, Saito M, Sugimoto K, Adachi K, Ohno T, Sunahara N, Katoh K, Tatemachi N, Takei Y: Lack of contribution of circulatory kinin elevated by captopril to induce hypotension in normotensive and hypertensive rats. Immunopharmacology 33, 291–293 (1996)

    Takei Y. , 'Lack of contribution of circulatory kinin elevated by captopril to induce hypotension in normotensive and hypertensive rats ' (1996 ) 33 Immunopharmacology : 291 -293.

    • Search Google Scholar
  • Saito M, Majima M, Katori M, Sanjou Y, Suyama I, Shiokawa H, Koshiba K, Aoyagi T: Degradation of bradykinin in human urine by carboxypeptidase Y-like exopeptidase and neutral endopeptidase and their inhibition by ebelactone B and phosphoramidon. Int. J. Tissue React. 17, 181–190 (1995)

    Aoyagi T. , 'Degradation of bradykinin in human urine by carboxypeptidase Y-like exopeptidase and neutral endopeptidase and their inhibition by ebelactone B and phosphoramidon ' (1995 ) 17 Int. J. Tissue React. : 181 -190.

    • Search Google Scholar
  • Majima M, Kuribayashi Y, Ikeda Y, Adachi K, Kato H, Katori M, Aoyagi T: Diuretic and natriuretic effect of ebelactone B in anesthetized rats by inhibition of a urinary carboxypeptidase Y-like kininase. Jpn. J. Pharmacol. 65, 79–82 (1995)

    Aoyagi T. , 'Diuretic and natriuretic effect of ebelactone B in anesthetized rats by inhibition of a urinary carboxypeptidase Y-like kininase ' (1995 ) 65 Jpn. J. Pharmacol. : 79 -82.

    • Search Google Scholar
  • Majima M, Shima C, Saito M, Kuribayashi Y, Katori M, Aoyagi T: Poststatin, a novel inhibitor of bradykinin-degrading enzymes in rat urine. Eur. J. Pharmacol. 232, 181–190 (1993)

    Aoyagi T. , 'Poststatin, a novel inhibitor of bradykinin-degrading enzymes in rat urine ' (1993 ) 232 Eur. J. Pharmacol. : 181 -190.

    • Search Google Scholar
  • Chao J, Chen LM, Xiong W, Chao S, Woodley-miller C, Wang L, Lu HS, Chao L: Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats. J. Biol. Chem. 265, 16394–16401 (1990)

    Chao L. , 'Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats ' (1990 ) 265 J. Biol. Chem. : 16394 -16401.

    • Search Google Scholar
  • Yang T, Terada Y, Nonoguchi H, Tsujino M, Tomita K, Marumo F: Distribution of kallikrein-binding protein mRNA in kidneys and difference between SHR and WKY. Am. J. Physiol. 267, F325–330 (1994)

    Marumo F. , 'Distribution of kallikrein-binding protein mRNA in kidneys and difference between SHR and WKY ' (1994 ) 267 Am. J. Physiol. : F325 -330.

    • Search Google Scholar
  • Hayashi I, Hoshiko S, Manabe O, Oh-ishi S: A point mutation of Alanine 163 to threonine is responsible for the defective secretion of high molecular weight kininogen by the liver of Brown Norway Katholiek rats. J. Biol. Chem. 268, 17219–17224 (1993)

    Oh-ishi S. , 'A point mutation of Alanine163 to threonine is responsible for the defective secretion of high molecular weight kininogen by the liver of Brown Norway Katholiek rats ' (1993 ) 268 J. Biol. Chem. : 17219 -17224.

    • Search Google Scholar
  • Majima M, Yoshida O, Mihara H, Muto T, Mizogami S, Kuribayashi Y, Katori M, Oh-ishi S: High sensitivity to salt in kininogen-deficient Brown Norway Katholiek rats. Hypertension 22, 705–714 (1993)

    Oh-ishi S. , 'High sensitivity to salt in kininogen-deficient Brown Norway Katholiek rats ' (1993 ) 22 Hypertension : 705 -714.

    • Search Google Scholar
  • Rhaleb N-E, Yang XP, Nanba M, Shesely EG, Carretero OA: Effect of chronic blockade of the kallikrein-kinin system on the development of hypertension in rats. Hypertension 37, 121–128 (2001)

    Carretero O.A. , 'Effect of chronic blockade of the kallikrein-kinin system on the development of hypertension in rats ' (2001 ) 37 Hypertension : 121 -128.

    • Search Google Scholar
  • Madeddu P, Varoni M, Palomba D, Emanueli C, Demontis MP, Gilorioso N, Gilorioso N, Dessl-Flgheri P, Sarizarni R, Anaia V: Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene. Circulation 96, 3570–3578 (1997)

    Anaia V. , 'Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene ' (1997 ) 96 Circulation : 3570 -3578.

    • Search Google Scholar
  • Alfie ME, Yang XP, Hess F, Carretero OA: Salt-sensitive hypertension in bradykinin B2 receptor knockout mice. Biochem. Biophys. Res. Commun. 224, 625–630 (1996)

    Carretero O.A. , 'Salt-sensitive hypertension in bradykinin B2 receptor knockout mice ' (1996 ) 224 Biochem. Biophys. Res. Commun. : 625 -630.

    • Search Google Scholar
  • Alfie ME, Sigmon DH, Pomposiello SI, Carretero OA: Effect of high salt intake in mutant mice lacking bradykinin-B 2 receptors. Hypertension 29, 483–487 (1997)

    Carretero O.A. , 'Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors ' (1997 ) 29 Hypertension : 483 -487.

    • Search Google Scholar
  • Majima M, Mizogami S, Kuribayashi Y, Katori M, Oh-ishi S: Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats. Hypertension 24, 111–119 (1994)

    Oh-ishi S. , 'Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats ' (1994 ) 24 Hypertension : 111 -119.

    • Search Google Scholar
  • Ward PE, Margolius HS (1979): Renal and urinary kallikrein. In: Bradykinin, Kallidin and Kallikrein. Vol. 25 (Suppl.), Ed. Erdős E, Springer-Verlag, Berlin, Heidelberg, New York, pp. 525–548

    Margolius H.S. , '', in Bradykinin, Kallidin and Kallikrein. Vol. 25 (Suppl.) , (1979 ) -.

  • Levinskey NG: The renal kallikrein-kinin system. Circ. Res. 44, 441–451 (1979)

    Levinskey N.G. , 'The renal kallikrein-kinin system ' (1979 ) 44 Circ. Res. : 441 -451.

  • Carretero OA, Scicli AG: The renal kallikrein-kinin system. Am. J. Physiol. 238, F247–255 (1980)

    Scicli A.G. , 'The renal kallikrein-kinin system ' (1980 ) 238 Am. J. Physiol. : F247 -255.

  • Mayfield RK, Margolius HS: Renal kallikrein-kinin system. Relation to renal function and blood pressure. Am. J. Nephrol. 3, 145–155 (1983)

    Margolius H.S. , 'Renal kallikrein-kinin system. Relation to renal function and blood pressure ' (1983 ) 3 Am. J. Nephrol. : 145 -155.

    • Search Google Scholar
  • Scicli AG, Carretero OA: Renal kallikrein-kinin system. Kidney Int. 29, 120–130 (1986)

    Carretero O.A. , 'Renal kallikrein-kinin system ' (1986 ) 29 Kidney Int. : 120 -130.

  • Margolius HS: Tissue kallikreins and kinins: Regulation and roles in hypertensive and diabetic diseases. Annu. Rev. Pharmacol. 29, 343–364 (1989)

    Margolius H.S. , 'Tissue kallikreins and kinins: Regulation and roles in hypertensive and diabetic diseases ' (1989 ) 29 Annu. Rev. Pharmacol. : 343 -364.

    • Search Google Scholar
  • Carretero OA, Scicli AG (1990): Kinins as regulators of blood flow and blood pressure. In: Hypertension: Pathology, Diagnosis, and Management. Eds. Laragh J, Brenner B., Raven Press, New York, pp. 805–817

    Scicli A.G. , '', in Hypertension: Pathology, Diagnosis, and Management , (1990 ) -.

  • Margolius HS: Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease. Hypertension 26, 221–229 (1995)

    Margolius H.S. , 'Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease ' (1995 ) 26 Hypertension : 221 -229.

    • Search Google Scholar
  • Mohsin SSJ, Majima M, Katori M, Sharma JN: Important suppressive roles of the kallikrein-kinin system during the developmental stage of hypertension in spontaneously hypertensive rats. Asia Pacific J. Pharmacol. 7, 73–82 (1992)

    Sharma J.N. , 'Important suppressive roles of the kallikrein-kinin system during the developmental stage of hypertension in spontaneously hypertensive rats ' (1992 ) 7 Asia Pacific J. Pharmacol. : 73 -82.

    • Search Google Scholar
  • Carretero OA, Polomski C, Hampton A, Scicli AG: Urinary kallikrein, plasma renin and aldosterone in New Zealand genetically hypertensive (GH) rats. Clin. Exp. Pharmacol. Physiol. 3(Suppl.), 55–59 (1976)

    Scicli A.G. , 'Urinary kallikrein, plasma renin and aldosterone in New Zealand genetically hypertensive (GH) rats ' (1976 ) 3 Clin. Exp. Pharmacol. Physiol. : 55 -59.

    • Search Google Scholar
  • Gilboa N, Rudofsky U, Margo A: Urinary and renal kallikrein in hypertensive fawn-hooded (FH/Wjd) rats. Lab. Invest. 50, 72–78 (1984)

    Margo A. , 'Urinary and renal kallikrein in hypertensive fawn-hooded (FH/Wjd) rats ' (1984 ) 50 Lab. Invest. : 72 -78.

    • Search Google Scholar
  • Porcelli G, Bianchi G, Croxatto HR: Urinary kallikrein excretion in a spontaneously hypertensive strain of rats. Proc. Natl. Acad. Sci. USA. 149, 983–986 (1975)

    Croxatto H.R. , 'Urinary kallikrein excretion in a spontaneously hypertensive strain of rats ' (1975 ) 149 Proc. Natl. Acad. Sci. USA. : 983 -986.

    • Search Google Scholar
  • Arbeit LA, Serra SR: Decreased total and active urinary kallikrein in normotensive Dahl salt susceptible rats. Kidney Int. 28, 440–446 (1985)

    Serra S.R. , 'Decreased total and active urinary kallikrein in normotensive Dahl salt susceptible rats ' (1985 ) 28 Kidney Int. : 440 -446.

    • Search Google Scholar
  • Rapp JP, Tan SY, Margolius HS: Plasma mineral corticoids, plasma renin, and urinary kallikrein in saltsensitive and salt-resistant rats. Endocr. Res. Commun. 5, 35–41 (1978)

    Margolius H.S. , 'Plasma mineral corticoids, plasma renin, and urinary kallikrein in saltsensitive and salt-resistant rats ' (1978 ) 5 Endocr. Res. Commun. : 35 -41.

    • Search Google Scholar
  • Majima M, Katori M, Hanazuka M, Mizogami S, Nakano T, Nakao Y, Mikami R, Uryu H, Okamura R, Mohsin SSJ, Oh-ishi S: Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system. Hypertension 17, 806–813 (1991)

    Oh-ishi S. , 'Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system ' (1991 ) 17 Hypertension : 806 -813.

    • Search Google Scholar
  • Ito H, Majima M, Nakajima S, Hayashi I, Katori M, Izumi T: Effect of prolonged administration of a urinary kininase inhibitor, ebelactone B on the development of doxycorticosterone acetate-salt hypertension in rats. Br. J. Pharmacol. 126, 613–620 (1999)

    Izumi T. , 'Effect of prolonged administration of a urinary kininase inhibitor, ebelactone B on the development of doxycorticosterone acetate-salt hypertension in rats ' (1999 ) 126 Br. J. Pharmacol. : 613 -620.

    • Search Google Scholar
  • Hayashi I, Majima M, Fujita T, Okumura T, Kumagai Y, Tomita N, Morishita R, Higaki J, Ogiwara T: In vivo transfer of antisense oligonucleotide against urinary kininase blunts deoxycorticosterone acetate-salt hypertension in rats. Br. J. Pharmacol. 131, 820–826 (2000)

    Ogiwara T. , 'In vivo transfer of antisense oligonucleotide against urinary kininase blunts deoxycorticosterone acetate-salt hypertension in rats ' (2000 ) 131 Br. J. Pharmacol. : 820 -826.

    • Search Google Scholar
  • Majima M, Adachi K, Kuribayashi Y, Mizogami S, Katori M: Increase in vascular sensitivity to angiotensin II and epinephrine after four-day infusion of 0.3 M sodium chloride in conscious kininogendeficient Brown Norway Katholiek rats. Jpn. J. Pharmacol. 69, 149–158 (1995)

    Katori M. , 'Increase in vascular sensitivity to angiotensin II and epinephrine after four-day infusion of 0.3 M sodium chloride in conscious kininogendeficient Brown Norway Katholiek rats ' (1995 ) 69 Jpn. J. Pharmacol. : 149 -158.

    • Search Google Scholar
  • Sasaki S, Takeda K, Okajima H, Takahashi H, Yoshimura M, Nakagawa M, Itiji H: Pressor responses to intracisternal injection of hypertonic NaCl in rats. J. Cardiovasc. Pharmacol. 6, 349–364 (2000)

    Itiji H. , 'Pressor responses to intracisternal injection of hypertonic NaCl in rats ' (2000 ) 6 J. Cardiovasc. Pharmacol. : 349 -364.

    • Search Google Scholar
  • Campese V, Karubian F, Chervu I, Parise M, Sarkies N, Bigazzi R.: Pressor reactivity to norepinephrine and angiotensin in salt-sensitive hypertensive patients. Hypertension 21, 301–307 (1993)

    Bigazzi R. , 'Pressor reactivity to norepinephrine and angiotensin in salt-sensitive hypertensive patients ' (1993 ) 21 Hypertension : 301 -307.

    • Search Google Scholar
  • Elliot AH, Nuzum FR: The urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension. Endocrinology 18, 462–474 (1934)

    Nuzum F.R. , 'The urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension ' (1934 ) 18 Endocrinology : 462 -474.

    • Search Google Scholar
  • Margolius HS, Geller RG, Pisano JJ, Sjoerdsma A: Altered urinary kallikrein excretion in human hypertension. Lancet ii, 1063–1065 (1971)

    Sjoerdsma A. , 'Altered urinary kallikrein excretion in human hypertension ' (1971 ) ii Lancet : 1063 -1065.

    • Search Google Scholar
  • Carretero OA, Scicli AG: The kallikrein-kinin system in human and in experimental hypertension. Klin. Wochenschr. 56(Suppl. 1), 113–125 (1978)

    Scicli A.G. , 'The kallikrein-kinin system in human and in experimental hypertension ' (1978 ) 56 Klin. Wochenschr. : 113 -125.

    • Search Google Scholar
  • Levy SB, Lilly JJ, Frigon RP, Stone LA: Urinary kallikrein and plasma renin activity as determinants of renal blood flow. J. Clin. Invest. 60, 129–138 (1977)

    Stone L.A. , 'Urinary kallikrein and plasma renin activity as determinants of renal blood flow ' (1977 ) 60 J. Clin. Invest. : 129 -138.

    • Search Google Scholar
  • Zinner SH, Margolius HS, Rosner B, Keiser HR, Rass EH: Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes. Am. J. Epidemiol. 104, 124–132 (1976)

    Rass E.H. , 'Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes ' (1976 ) 104 Am. J. Epidemiol. : 124 -132.

    • Search Google Scholar
  • Zinner SH, Margolius HS, Rosner B, Kass EH: Stability of blood pressure rank and urinary kallikrein concentration in childhood: An eight-year follow-up. Circulation 58, 908–915 (1978)

    Kass E.H. , 'Stability of blood pressure rank and urinary kallikrein concentration in childhood: An eight-year follow-up ' (1978 ) 58 Circulation : 908 -915.

    • Search Google Scholar
  • Hunt SC, Hasstedt SJ, Wu LL, Williams RR: A gene-enviromental interaction between inferred kallikrein genotype and potassium. Hypertension 22, 161–168 (1993)

    Williams R.R. , 'A gene-enviromental interaction between inferred kallikrein genotype and potassium ' (1993 ) 22 Hypertension : 161 -168.

    • Search Google Scholar
  • Barlow R, Connell M, Levendig B, Gear J, Milne F: A comparative study of urinary sodium and potassium excretion in normotensive urban black and white South African males. S. Af. Med. J. 62, 939–941 (1982)

    Milne F. , 'A comparative study of urinary sodium and potassium excretion in normotensive urban black and white South African males ' (1982 ) 62 S. Af. Med. J. : 939 -941.

    • Search Google Scholar
  • Barlow R, Connell M, Milne F: A study of 48-hour faecal and urinary electrolyte excretion in normotensive black and white South African males. J. Hypertens. 4, 197–200 (1986)

    Milne F. , 'A study of 48-hour faecal and urinary electrolyte excretion in normotensive black and white South African males ' (1986 ) 4 J. Hypertens. : 197 -200.

    • Search Google Scholar
  • Luft F, Grim C, Fineberg N, Weinberger M: Effects of volume expansion and contraction in normotensive whites, blacks and subjects of different ages. Circulation 59, 643–650 (1979)

    Weinberger M. , 'Effects of volume expansion and contraction in normotensive whites, blacks and subjects of different ages ' (1979 ) 59 Circulation : 643 -650.

    • Search Google Scholar
  • Pratt JH, Rebhun JF, Zhou L, Ambrosius WT, Newman SA, Gomex-Sanchez CE, Mayers DF: Levels of mineralocorticoids in whites and blacks. Hypertension 34, 315–319 (1999)

    Mayers D.F. , 'Levels of mineralocorticoids in whites and blacks ' (1999 ) 34 Hypertension : 315 -319.

    • Search Google Scholar
  • Luft F, Rankin L, Bloch R, Weyman A, Willis L, Murray R, Grim C, Weinberger M: Cardiovascular and humoral responses to extreme of sodium intake in normal black and white men. Circulation 60, 697–706 (1979)

    Weinberger M. , 'Cardiovascular and humoral responses to extreme of sodium intake in normal black and white men ' (1979 ) 60 Circulation : 697 -706.

    • Search Google Scholar
  • Whelton P, He J, Cutler J, Brancati F, Appel L, Follmann D, Klag M: Effects of oral potassium on blood pressure, meta-analysis of randomized controlled trials. J. Am. Med. Assoc. 277, 1624–1632 (1997)

    Klag M. , 'Effects of oral potassium on blood pressure, meta-analysis of randomized controlled trials ' (1997 ) 277 J. Am. Med. Assoc. : 1624 -1632.

    • Search Google Scholar
  • Morris RCJ, Sebastian A, Forman A, Tanaka K, Schmidlin O: Normotensive salt sensitivity. Effects of race and dietary potassium. Hypertension 33, 18–23 (1999)

    Schmidlin O. , 'Normotensive salt sensitivity. Effects of race and dietary potassium ' (1999 ) 33 Hypertension : 18 -23.

    • Search Google Scholar
  • Bailin L, Rouse I, Armstrong B, Margetts B, Vandongen R: Vegetarian diet and blood pressure levels: incidental or causal association? Am. J. Clin. Nutr. 48, 806–810 (1988)

    Vandongen R. , 'Vegetarian diet and blood pressure levels: incidental or causal association? ' (1988 ) 48 Am. J. Clin. Nutr. : 806 -810.

    • Search Google Scholar
  • Schmidlin O, Forman A, Tanaka M, Sebastian A, Morris RCJ: NaCl-induced renal vasoconstriction in salt-sensitive African Americans. Antipressor and hemodynamic effects of potassium bicarbonate. Hypertension 33, 633–639 (1999)

    Morris R.C.J. , 'NaCl-induced renal vasoconstriction in salt-sensitive African Americans. Antipressor and hemodynamic effects of potassium bicarbonate ' (1999 ) 33 Hypertension : 633 -639.

    • Search Google Scholar
  • Williams RR, Hunt SC, Hoplins P, Wu L, Hasstedt SJ, Berry TD, Barlow GK, Lifton RP, Lalouel JM: Genetic basis of familial dyslipidemia and hypertension: 15-years results from Utah. Am. J. Hypertens. 6, 319S–327S (1993)

    Lalouel J.M. , 'Genetic basis of familial dyslipidemia and hypertension: 15-years results from Utah ' (1993 ) 6 Am. J. Hypertens. : 319S -327S.

    • Search Google Scholar
  • Staessen JA, Birkheger W, Bulpitt CJ, Fagard R, Fletcher AF, Lijnen P, Thijis I, Amery A: The relationship between blood pressure and sodium and potassium excretion during the day and night. J. Hypertens. 11, 443–447 (1993)

    Amery A. , 'The relationship between blood pressure and sodium and potassium excretion during the day and night ' (1993 ) 11 J. Hypertens. : 443 -447.

    • Search Google Scholar
  • Ueno M, Kawasaki T, Uezono K, Omae T, Matsuoka M: Relationship of urinary kallikrein excretion to renal water and sodium excretion. Metabolism 32, 433–437 (1983)

    Matsuoka M. , 'Relationship of urinary kallikrein excretion to renal water and sodium excretion ' (1983 ) 32 Metabolism : 433 -437.

    • Search Google Scholar
  • Albano J, Campbell S, Farrer A, Millar J: Gender differences in urinary kallikrein excretion in man: variation throughout the menstrual cycle. Clin. Sci. (London) 86, 227–231 (1994)

    Millar J. , 'Gender differences in urinary kallikrein excretion in man: variation throughout the menstrual cycle ' (1994 ) 86 Clin. Sci. (London) : 227 -231.

    • Search Google Scholar
  • Kailasam M, Martinez J, Cervenka J, Yen S, O’connor D, Parmer R: Racial differences in renal kallikrein excretion: effect of the ovulatory cycle. Kidney Int. 54, 1652–1658 (1998)

    Parmer R. , 'Racial differences in renal kallikrein excretion: effect of the ovulatory cycle ' (1998 ) 54 Kidney Int. : 1652 -1658.

    • Search Google Scholar
  • Horwitz D, Margolius HS, Keiser HR: Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man. J. Clin. Endocrinol. Metab. 47, 296–299 (1978)

    Keiser H.R. , 'Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man ' (1978 ) 47 J. Clin. Endocrinol. Metab. : 296 -299.

    • Search Google Scholar
  • Smith GJ, Klotman PE, Sventkey LP: Potassium chloride lowers blood pressure and caused natriuresis in older patients with hypertension. J. Am. Soc. Nephrol. 2, 1302–1309 (1992)

    Sventkey L.P. , 'Potassium chloride lowers blood pressure and caused natriuresis in older patients with hypertension ' (1992 ) 2 J. Am. Soc. Nephrol. : 1302 -1309.

    • Search Google Scholar
  • Muto S: Potassium transport in the mammalian collecting duct. Physiol. Rev. 81, 85–116 (2001)

    Muto S. , 'Potassium transport in the mammalian collecting duct ' (2001 ) 81 Physiol. Rev. : 85 -116.

    • Search Google Scholar
  • Vio CP, Figueroa CD: Evidence for a stimulatory effect of high potassium diet on renal kallikrein. Kidney Int. 31, 1327–1334 (1987)

    Figueroa C.D. , 'Evidence for a stimulatory effect of high potassium diet on renal kallikrein ' (1987 ) 31 Kidney Int. : 1327 -1334.

    • Search Google Scholar
  • Suzuki T, Katori M, Fujita T, Kumagai Y, Majima M: Involvement of the renal kallikrein-kinin system in K + -induced diuresis and natriuresis in anesthetized rats. Eur. J. Pharmacol. 399, 223–227 (2000)

    Majima M. , 'Involvement of the renal kallikrein-kinin system in K+-induced diuresis and natriuresis in anesthetized rats ' (2000 ) 399 Eur. J. Pharmacol. : 223 -227.

    • Search Google Scholar
  • Hayashi I: A secretary mechanism of renal kallikrein by a high potassium ion; a possible involvement of ATP-sensitive potassium channel. Immunopharmacology 44, 49–55 (1999)

    Hayashi I. , 'A secretary mechanism of renal kallikrein by a high potassium ion; a possible involvement of ATP-sensitive potassium channel ' (1999 ) 44 Immunopharmacology : 49 -55.

    • Search Google Scholar
  • Fujita T, Hayashi I, Kumagai Y, Imamura N, Majima M: Early increase in renal kallikrein excretion on administration of potassium or ATP-sensitive potassium channel blockers in rats. Br. J. Pharmacol. 128, 1275–1283 (1999)

    Majima M. , 'Early increase in renal kallikrein excretion on administration of potassium or ATP-sensitive potassium channel blockers in rats ' (1999 ) 128 Br. J. Pharmacol. : 1275 -1283.

    • Search Google Scholar
  • Guillemare E, Honore E, Wille JD, Fosset M, Lazdunski M, Meisheri K: Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K + channel blocker: comparison with rat insulinoma cells. Mol. Pharmacol. 46, 139–145 (1994)

    Meisheri K. , 'Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells ' (1994 ) 46 Mol. Pharmacol. : 139 -145.

    • Search Google Scholar
  • Bönner G, Thieven B, Rütten H, Chrosch R, Krone W: Renal kallikrein is a determinant of salt sensitivity. J. Hypertens. 11(Suppl. 5), S210–211 (1993)

    Krone W. , 'Renal kallikrein is a determinant of salt sensitivity ' (1993 ) 11 J. Hypertens. : S210 -211.

    • Search Google Scholar
  • Ferri C, Bellini C, Carlomagno A, Perrone A, Santucci A: Urinary kallikrein and salt sensitivity in essential hypertensive males. Kidney Int. 46, 780–788 (1994).

    Santucci A. , 'Urinary kallikrein and salt sensitivity in essential hypertensive males ' (1994 ) 46 Kidney Int. : 780 -788.

    • Search Google Scholar

The author instruction is available in PDF.

Please, download the file from HERE

  • Impact Factor (2016): 0.571
  • 5-year Impact Factor (2016): 0.675
  • Physiology (Medical) Quartile score (2016): Q4
  • SJR Indicator (2016): 0.276
  • H-Index (2016): H-Index (2016): 23

Language: English

Founded in 1950
Publication: One volume of four issues annually
Publication Programme: 2016: Vol. 103
Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • EMBASE/Excerpta Medica
  • Global Health
  • Index Copernicus
  • Index Medicus
  • Medline
  • Referativnyi Zhurnal
  • Science Citation Index Expanded
  • SCOPUS

 

Subscribers can access the electronic version of every printed article.

Senior editors

Editor(s)-in-Chief: Rosivall, László

Honorary Editor(s)-in-Chief): Monos, Emil

Managing Editor(s): Bartha, Jenő; Berhidi, Anna

Co-editor(s): Koller, Ákos; Lénárd, László; Szénási, Gábor

Assistant Editor(s): G. Dörnyei (Budapest), Zs. Miklós (Budapest), Gy. Nádasy (Budapest)

Hungarian Editorial Board

      Benedek, György (Szeged)
      Benyó, Zoltán (Budapest)
      Boros, Mihály (Szeged)
      Chernoch, László (Debrecen)
      Détári, László (Budapest)
      Hamar, János (Budapest)
      Hantos, Zoltán (Szeged)
      Hunyady, László (Budapest)
      Imre, Sándor (Debrecen)
      Jancsó, Gábor (Szeged)
      Karádi, Zoltán (Pécs)
      Kovács, László (Debrecen)
      Palkovits, Miklós (Budapest)
      Papp, Gyula (Szeged)
      Pavlik, Gábor (Budapest)
      Spät, András (Budapest)
      Szabó, Gyula (Szeged)
      Szelényi, Zoltán (Pécs)
      Szolcsányi, János (Pécs)
      Szollár, Lajos (Budapest)
      Szücs, Géza (Debrecen)
      Telegdy, Gyula (Szeged)
      Toldi, József (Szeged)
      Tósaki, Árpád (Debrecen)

International Editorial Board

      R. Bauer (Jena)
      W. Benjelloun (Rabat)
      A. W. Cowley Jr. (Milwaukee)
      D. Djuric (Belgrade)
      C. Fry (London)
      S. Greenwald (London)
      O. Hänninen (Kuopio)
      H. G. Hinghofer-Szalkay (Graz)
      Th. Kenner (Graz)
      Gy. Kunos (Richmond)
      M. Mahmoudian (Tehran)
      T. Mano (Seki, Gifu)
      G. Navar (New Orleans)
      H. Nishino (Nagoya)
      O. Petersen (Liverpool)
      U. Pohl (Münich)
      R. S. Reneman (Maastricht)
      A. Romanovsky (Phoenix)
      G. M. Rubanyi (Richmond)
      T. Sakata (Oita)
      A. Siddiqui (Karachi)
      Cs. Szabo (Beverly)
      E. Vicaut (Paris)
      N. Westerhof (Amsterdam)
      L. F. Zhang (Xi'an)

Editorial Office:
Akadémiai Kiadó Zrt.
Prielle Kornélia u. 21–35, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Physiologica Hungarica
Semmelweis University, Faculty of Medicine Institute of Pathophysiology
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: aph@semmelweis-univ.hu